ARTICLE | Clinical News
Oleylphosphocholine regulatory update
May 28, 2012 7:00 AM UTC
The European Commission granted Orphan Drug designation for Dafra's oleylphosphocholine to treat leishmaniasis. Dafra has exclusive, worldwide rights to the alkylphosphocholine derivative from the Max...